Will Novavax Stock Jump Another 25% This Year?

1 min read

Novavax (NASDAQ: NVAX) ranked as the best-performing COVID-19 vaccine stock in 2020. It’s off to a fantastic start in 2021 as well with a triple-digit-percentage gain. In this Motley Fool Live video recorded on Feb. 3, Fool.com contributors Keith Speights and Brian Orelli discuss whether or not Novavax stock can tack on another 25% this year.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Why Is Fulgent Genetics Stock So Volatile?

Next Story

Here’s Why More People Could Lose Out on Free Tax-Filing Help This Year

Latest from Blog